# mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mtor-inhibition-is-most-beneficial-after-liver-transplantation-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andreas A. Schnitzbauer,Natalie Filmann,René Adam,Philippe Bachellier,Wolf O. Bechstein,Thomas Becker,Sherrie Bhoori,Itxarone Bilbao,Jens Brockmann,Patrizia Burra,O. Chazoullières,Umberto Cillo,M. Colledan,C. Duvoux,Tom M. Ganten,Jean Gugenheim,Michael Heise,Bart van Hoek,Neville V. Jamieson,Koert P. de Jong,Christian Klein,Jürgen Klempnauer,Norman M. Kneteman,Jan Lerut,Heikki Mäkisalo,Vincenzo Mazzaferro,Darius F. Mirza,Silvio Nadalin,P. Neuhaus,G.-P. Pageaux,Antonio Daniele Pinna,Jaques Pirenne,Johann Pratschke,James Powel,Markus Rentsch,Magnus Rizell,G. Rossi,Lionel Rostaing,André Roy,Tim Scholz,Utz Settmacher,Thomas Soliman,Simone I. Strasser,Gunnar Söderdahl,Roberto Troisi,Víctor Sánchez Turrión,Hans J. Schlitt,Edward K. Geissler |
| Citations | 139 |
| DOI | 10.1097/sla.0000000000004280 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://lirias.kuleuven.be/handle/123456789/659833 |
| OpenAlex ID | https://openalex.org/W3083759464 |
| PMID | 32889867 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Heikki Mäkisalo](https://scholariq.org/researchers/heikki-makisalo/)

## Paper journal

- [Annals of Surgery](https://scholariq.org/journals/annals-of-surgery/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.